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S374 Poster Session IIto be characterized. Stem cells with pluripotent properties, including
unrestricted somatic stem cells (USSCs) have been isolated from
HUCB and may represent novel stem cells for the RDEB regenera-
tive therapy (Liao/Cairo et al, Exp. Hem, 2011).
Goal: To determine the potential of USSCs in promoting wound
healing and treating RDEB.
Method: USSCs were isolated from HUCB and characterized by
flow cytometry, RT-PCR, bisulfate sequencing and immunocyto-
chemistry. A 1cm2 full-thickness excisional wound was created at
the dorsal of NSG mice, followed by intradermal injection of 1 mil-
lionUSSCs or PBS at a 1cm- distance from themargin of the wound.
Results: USSCs transcribe a low level of ES factors and have a mo-
saic DNA methylation pattern at the regulatory regions of Nanog
and Oct4. USSCs express Col7a1 at a level that is comparable to hu-
man keratinocytes and fibroblasts. Through an initial treatment of
ascorbic acid, EGF and BMP4 for 7 days followed by culture in de-
fined K-SFMmedium, USSCs were able to differentiate and express
keratinocyte- specific genes. In the mouse wounding model, the
wounds closed at a faster rate in USSC-treated mice as compared
to PBS and a significant difference was observed between the two
groups on days 6-10 post wounding (F(1,168) 5 50.8, P\0.01).
USSCs promoted epithelialization and facilitated formation and re-
modeling of epidermis. More host-derived endothelial cells (PE-
CAM+) were recruited to the USSC-treated wounds as early as
three days post wounding. Furthermore, the USSC-treated skin
healed with skin appendages in the center of the wounded area.
However human cells could be sporadically detected only in the basal
membrane in skin sections without apparent differentiation. This
suggests that the improved murine wound healing is due to a para-
crine effect of USSCs.
Conclusion:HUCB- USSCs showed beneficial effects in cutaneous
regeneration. The ability of USSCs to express Col7A1 and promote
wound healing suggests their potential application in the RDEB
therapy.
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SERINE/THREONINE PIM KINASES PLAY AN IMPORTANT ROLE IN MAIN-
TAINING THE NUMBER AND FUNCTION OF HEMATOPOIETIC STEM CELLS
An, N.1, Lin, Y.-W.2, Liu, A.1, Lilly, M.3, Mahajan, S.1, Kraft, A.1,
Kang, Y.1 1Medical University of South Carolina, Charleston, SC;
2Date Red Cross Hospital, Hokkaido, Japan; 3University of California
Irvine, Irvine, CA
Pim (proviral insertion in murine lymphoma) kinases are a small
family of constitutively active, highly conserved serine/threonine ki-
nases, and have 3 members (Pim1, 2 and 3). The roles of Pim kinases
in the regulation of hematopoietic stem cells (HSCs) are currently
unknown. In the current study, we used transgenic (Tx) and knock-
out (KO) mouse models to characterize the roles of Pim kinases in
hematopoiesis. We generated Pim1 Tx mice bearing human Pim1
kinase under the vav- hematopoietic regulatory elements (vav-
hPim1). Pim1, 2 and 3 single, double and triple KO mice were
also used in this study.We found that: 1). Vav-hPim1Txmice devel-
oped lymphoid, but not myeloid, malignancies. About 10% of vav-
hPim1 Tx mice developed lymphoid leukemia/lymphoma. 2). Vav-
hPim1 Tx mice had increased hematopoietic stem/progenitor cell
(HSPC) population. In those vav-hPim1 Tx mice that were free of
leukemia/lymphoma, a more than 2 fold increase in the number of
c-Kit+Sca-1+Lin- (LSK) HSPCs were noted when compared to
age-matched, wild-type littermates (p less than 0.05). Vav-hPim1
Tx mice exhibited enlarged spleen, higher CXCR4 surface expres-
sion and increased colony forming units (CFUs). Additionally, le-
thally irradiated mice transplanted with splenocytes from vav-
hPIM1 Tx mice had better survival compared to those transplanted
with splenocytes from wild-type control mice. 3). Pim1, 2, 3 single
KO mice had relatively unchanged HSPCs, while Pim1/2, Pim2/3
double KO and Pim1/2/3 triple KO mice exhibited decreased
HSPCs, suggesting potential overlap in function of Pim1, 2, 3 kinase.
When compared to wild-type littermate controls, Pim double or tri-
ple KOmice exhibited lower number of LSKHSPCs, lower CXCR4
surface expression, and reduced CFUs. Furthermore, lethally irradi-
ated mice transplanted with marrow cells from Pim double or triple
KO mice had much slower hematopoietic recovery, compared to
those receiving marrow from normal control mice. 4). IL-3, IL-6
and Thrombopoietin upregulated Pim1 expression in Lin- marrowcells. Stem cell factor and Flt-3 had no effect on Pim 1 expression.
5). Over-expression of Pim1 kinase led to up-regulation of transcrip-
tion factor genes important in the sonic Hedgehog signaling, illus-
trating a potential mechanism through which Pim1 enhances
hematopoiesis. In conclusion, our studies demonstrate a novel role
of Pim serine/threonine kinases in hematopoiesis, and provide
a novel molecular mechanism in the regulation of HSCs.
463
ENDOTHELIAL PROGENITOR CELL MOBILIZATION IN C57BL/6 MICE
FOLLOWING TREATMENT WITH SINGLE AGENT OR COMBINATION
NEUPOGEN (G-CSF), PLERIXAFOR (AMD3100), AND VEGF
Frank, R.R.1, Jagan, S.1, Paganessi, L.A.1, McNulty, M.A.2,
Sumner, D.R.2, Fung, H.C.1, Gregory, S.A.1, Christopherson, K.W.1,2
1Rush University Medical Center, Chicago, IL; 2Rush University Medical
Center, Chicago, IL
Introduction: Bone marrow (BM) derived endothelial progenitor
cells (EPC) can differentiate to form vasculature. It is thought that
EPC have a potential role in homeostasis of the endothelium as
well as repair after ischemia or other endothelial injury by inducing
neovasculatization. Successful mobilization of EPC from the BM
into the peripheral blood (PB) would allow for relative ease of collec-
tion and use for cell therapy.
Methods: A screen of 10 agents in C57BL/6mice identifiedG-CSF,
AMD3100, and VEGF as agents that resulted in a$ 2-fold increase
in circulating EPC. Subsequently, neupogen (G-CSF, 50g/kg SC
twice a day for 4 days), plerixafor (AMD3100, 5mg/kg SC, once 1
hr prior), andVEGF (50g/kg SC twice a day for 4 days) were assessed
in individual mice (N5 5) as single agents or in combination. PB and
BM were collected and plated for colony formation at 5%CO2 5%
O2. After 14 days, total EPC and EPC subtypes corresponding to en-
dothelial colony-forming cells (ECFC) and colony-forming units
(CFU-EC), as previously reported by Yoder, et al. Blood 2007,
were scored. In parallel, hematopoietic progenitors (CFU-GM,
BFU-E, & CFU-GEMM) were evaluated after 7 days in culture.
Data is presented as colonies /mL PB or /femur6SEM and analyzed
using Mann-Whitney U test.
Results: Analysis of data indicates, as compared to saline, that treat-
ment with single agent G-CSF, AMD3100, or VEGF results in sig-
nificant mobilization of total EPC into the PB (3.762.1, 61.067.7,
60.463.8, or 37.966.7 CFU/mL respectively, p\0.05). In addition,
the total EPC in the PB increased further with the combination
G-CSF+AMD3100 (95.369.4 CFU/mL, p\0.05) but not
G-CSF+VEGF, VEGF+AMD3100, or G-CSF+VEGF+AMD3100
(65.3615.7, 56.167.7, 54.9618.9 CFU/mL respectively). In all
cases the majority of EPC mobilized into the PB were CFU-EC.
Only AMD3100 mobilized significant numbers of ECFC
(p\0.05). In the BM, total EPC and ECFC decreased in response
to G-CSF but not VEGF or VEGF+AMD3100. G-CSF and
AMD3100 containing regimens but not single agent VEGF mobi-
lized CFU-GM, BFU-E, and CFU-GEMM into the PB (p\0.05).
Conclusion: Treatment with single agent or combination G-CSF,
AMD3100, and VEGF mobilize significant numbers of EPC into
the PB. However, only AMD3100 significantly mobilizes the ECFC
subtype ofEPC that has been reported to formcapillary-like structures
and micro-vessels. Further studies are warranted to assess potential
therapeutic outcomes of mobilized EPC in disease model systems.464
MESENCHYMAL STEM CELLS ENHANCED METASTASIS OF NEUROBLAS-
TOMA VIA SDF-1/CXCR4 AND SDF-1/CXCR7 SIGNALLING
Ma,M., Chan, G.C.-F. The University of Hong Kong, Hong Kong, Hong
Kong
Background&Objective:Bonemarrow is a frequentmetastatic site
for neuroblastoma. The SDF-1/CXCR4 axis has long been proposed
as an important pathway duringmetastasis of various cancers, includ-
ing neuroblastoma (Zhang L, et al. 2007). But the expression and
function of CXCR7, the other known receptor for SDF-1, in meta-
static neuroblastoma has yet to be defined. We investigated the che-
motactic effects of neuroblastma cells towards human bone marrow
mesenchymal stem cells (MSCs) induced by the above two pathways.
